Frank Reichenberger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Frank Reichenberger has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Christian Tanislav
Department of Neurology, University Hospital Giessen, 35392 Giessen, Germany
3 shared publications - Andreas Feustel
Departments of Nephrology, Justus Liebig University Giessen, Giessen, Germany
2 shared publications - Manfred Kaps
Klinik und Poliklinik für Neurologie, Universitätsklinikum Giessen, Giessen
2 shared publications - Nicole Sieweke
Department of Neurology, Justus Liebig University, Giessen, Germany
2 shared publications - Wolfgang Pabst
Institute for Biomedicine and Epidemiology, Justus Liebig University, Giessen, Germany
2 shared publications - Arndt Rolfs
Albrecht-Kossel-Institute for Neuroregeneration (AKos), University Medicine Rostock, Gehlsheimer Straße 20, 18147 Rostock, Germany
1 shared publication
Latest Publications
- Open Access
- 17 July 2012
- Published by Springer Nature in BMC Neurology
- Vol. 12 (1) , 58
Cardiac Troponin I elevation after epileptic seizure
Background: Cardiac troponin-I (cTNI) is highly specific biomarker to prove myocardial damage, e.g. in acute coronary syndrome (ACS). However, it occurs in other conditions as well. We therefore analysed cTNI increase in patients after generalized convulsive seizure. Methods: Consecutive patients admitted with acute generalized convulsive seizure were included in case of cTNI measurement on admission. Among 898 selected cases, 53 patients were referred secondary to our department; in 845 cases cTNI measurements on admission were available. In case of multiple admissions (81 cases), only the first admission entered our analysis. In 17 patients elevated cTNI was determined due to ACS; in one patient a myocarditis was found. 5 patients suffered of relevant renal insufficiency. Finally 741 patients were included in the analysis. A cTNI cut-off level of ≥ 0.1 ng/ml was considered. Factors associated with a cTNI increase were analysed subsequently. Results: The mean age of the study population (n = 741) was 47.8 years (SD ± 18.6), 40.9% were female. In 50 patients (6.7%) a cTNI elevation of unknown origin was found; no obvious cardiac involvement could be detected in these patients who all remained asymptomatic. A vascular risk profile (including at least hypertension, hypercholesterolemia or diabetes) (OR = 3.62; CI: 1.59 to 8.21; p = 0.001) and elevated creatine kinase on admission (OR = 2.36; CI: 1.26 to 4.39; p = 0.002) were independent factors associated with cTNI release. Conclusion: cTNI release occurs in patients with generalized convulsive seizure with predominance in patients with vascular risk profile.
- 17 July 2012
- Published by Springer Nature in BMC Neurology
- Vol. 12 (1) , 58
Open AccessCardiac Troponin I elevation after epileptic seizure
Background: Cardiac troponin-I (cTNI) is highly specific biomarker to prove myocardial damage, e.g. in acute coronary syndrome (ACS). However, it occurs in other conditions as well. We therefore analysed cTNI increase in patients after generalized convulsive seizure. Methods: Consecutive patients admitted with acute generalized convulsive seizure were included in case of cTNI measurement on admission. Among 898 selected cases, 53 patients were referred secondary to our department; in 845 cases cTNI measurements on admission were available. In case of multiple admissions (81 cases), only the first admission entered our analysis. In 17 patients elevated cTNI was determined due to ACS; in one patient a myocarditis was found. 5 patients suffered of relevant renal insufficiency. Finally 741 patients were included in the analysis. A cTNI cut-off level of ≥ 0.1 ng/ml was considered. Factors associated with a cTNI increase were analysed subsequently. Results: The mean age of the study population (n = 741) was 47.8 years (SD ± 18.6), 40.9% were female. In 50 patients (6.7%) a cTNI elevation of unknown origin was found; no obvious cardiac involvement could be detected in these patients who all remained asymptomatic. A vascular risk profile (including at least hypertension, hypercholesterolemia or diabetes) (OR = 3.62; CI: 1.59 to 8.21; p = 0.001) and elevated creatine kinase on admission (OR = 2.36; CI: 1.26 to 4.39; p = 0.002) were independent factors associated with cTNI release. Conclusion: cTNI release occurs in patients with generalized convulsive seizure with predominance in patients with vascular risk profile.
- Open Access
- 31 January 2011
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 11 (1) , 6
Persistent increase in cardiac troponin I in Fabry disease: a case report
Hypertrophic cardiomyopathy is a frequent manifestation in Fabry disease (FD) - an X-linked lysosomal storage disorder caused by reduced activity of the enzyme α-galactosidase A. In FD an elevation of specific cardiac biomarkers, such as cardiac troponin I (cTNI) has been reported in case of clinical manifestation suggestive of myocardial ischemia. In diagnosing acute myocardial infarction cTNI is considered the most reliable parameter.
- 31 January 2011
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 11 (1) , 6
Open AccessPersistent increase in cardiac troponin I in Fabry disease: a case report
Hypertrophic cardiomyopathy is a frequent manifestation in Fabry disease (FD) - an X-linked lysosomal storage disorder caused by reduced activity of the enzyme α-galactosidase A. In FD an elevation of specific cardiac biomarkers, such as cardiac troponin I (cTNI) has been reported in case of clinical manifestation suggestive of myocardial ischemia. In diagnosing acute myocardial infarction cTNI is considered the most reliable parameter.
- Open Access
- 29 December 2010
- Published by Springer Nature in BMC Neurology
- Vol. 10 (1) , 123
Decrease in shunt volume in patients with cryptogenic stroke and patent foramen ovale
In patients with patent foramen ovale (PFO) there is evidence supporting the hypothesis of a change in right-to-left shunt (RLS) over time. Proven, this could have implications for the care of patients with PFO and a history of stroke. The following study addressed this hypothesis in a cohort of patients with stroke and PFO.
- 29 December 2010
- Published by Springer Nature in BMC Neurology
- Vol. 10 (1) , 123
Open AccessDecrease in shunt volume in patients with cryptogenic stroke and patent foramen ovale
In patients with patent foramen ovale (PFO) there is evidence supporting the hypothesis of a change in right-to-left shunt (RLS) over time. Proven, this could have implications for the care of patients with PFO and a history of stroke. The following study addressed this hypothesis in a cohort of patients with stroke and PFO.